TimesSquare Capital Management LLC Decreases Position in Addus HomeCare Corporation $ADUS

TimesSquare Capital Management LLC lessened its holdings in Addus HomeCare Corporation (NASDAQ:ADUSFree Report) by 15.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 355,337 shares of the company’s stock after selling 63,011 shares during the quarter. TimesSquare Capital Management LLC’s holdings in Addus HomeCare were worth $38,160,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Larson Financial Group LLC raised its position in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the period. Private Trust Co. NA raised its position in Addus HomeCare by 65.5% in the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after purchasing an additional 112 shares during the period. AlphaQuest LLC purchased a new position in Addus HomeCare in the 3rd quarter worth $37,000. Wexford Capital LP purchased a new position in Addus HomeCare in the 3rd quarter worth $41,000. Finally, State of Wyoming purchased a new position in Addus HomeCare in the 2nd quarter worth $47,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently commented on ADUS. Barclays decreased their target price on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research report on Friday. Citizens Jmp reiterated a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Monday. KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Stephens decreased their price objective on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. Finally, Wall Street Zen cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $131.22.

Check Out Our Latest Stock Analysis on ADUS

Addus HomeCare Price Performance

ADUS stock opened at $92.64 on Tuesday. The firm’s 50-day moving average price is $96.50 and its two-hundred day moving average price is $106.11. Addus HomeCare Corporation has a 12-month low of $89.76 and a 12-month high of $124.43. The stock has a market capitalization of $1.73 billion, a price-to-earnings ratio of 17.12, a PEG ratio of 1.25 and a beta of 0.92. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. During the same quarter in the previous year, the company earned $1.42 earnings per share. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. As a group, equities analysts predict that Addus HomeCare Corporation will post 6.24 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other news, EVP David W. Tucker sold 704 shares of Addus HomeCare stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $107.35, for a total transaction of $75,574.40. Following the sale, the executive vice president owned 10,802 shares of the company’s stock, valued at approximately $1,159,594.70. The trade was a 6.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Sean Gaffney sold 817 shares of Addus HomeCare stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $87,402.66. Following the sale, the executive vice president directly owned 20,522 shares in the company, valued at $2,195,443.56. The trade was a 3.83% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 16,788 shares of company stock valued at $1,785,633. Company insiders own 4.50% of the company’s stock.

Addus HomeCare Profile

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Articles

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.